|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ch. 61 2000 LAWS OF MARYLAND
|
|
|
|
|
|
|
|
|
Occurred: Ch. 683, Acts of 1999. Correction by the publisher of the
Annotated Code in the 1999 Supplement of the Insurance Article is
validated by this Act.
15-827.
(e) The coverage under subsection (d) of this section shall be required if:
(1) (i) the treatment is being provided or the studies are being
conducted in a Phase I, Phase II, Phase III, or Phase IV clinical trial for cancer; or
(ii) the treatment is being provided in a Phase I, Phase II, Phase
III, or Phase IV clinical trial for any other life-threatening condition;
(2) the treatment is being provided in a clinical trial approved by:
(i) one of the National Institutes of Health;
(ii) an NIH cooperative group or an NIH center;
(iii) the FDA in the form of an investigational new drug application;
(iv) the federal Department of Veterans Affairs; or
(v) an institutional review board of an institution in the state
which has a multiple project assurance contract approved by the Office of Protection
from Research Risks of the National Institutes of Health;
(3) the facility and personnel providing the treatment are capable of
doing so by virtue of their experience, training, and volume of patients treated to
maintain expertise;
(4) there is no clearly superior, noninvestigational treatment alternative;
and
(5) the available clinical or preclinical data provide a reasonable
expectation that the treatment will be at least as effective as the noninvestigational
alternative.
DRAFTER'S NOTE:
Error: Incorrect word usage in § 15-827(e)(2)(v) of the Insurance Article.
Occurred: Chs. 145 and 146, Acts of 1999. Correction by the publisher of
the Annotated Code in the 1999 Supplement of the Insurance Article is
validated by this Act.
17-201.
(b) (1) The employees eligible for insurance under the policy shall be all of
the employees of the employer, or all [or] OF any class or classes of employees.
DRAFTER'S NOTE:
Error: Incorrect word usage in § 17-201(b)(l) of the Insurance Article.
|
|
|
|
|
|
|
|
|
|
- 546 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
